2026 Sponsors
Abbott Vascular Life changing cardiac and Vascular technology company
Acera Surgical is dedicated to developing groundbreaking products like Restrata, the first electrospun fiber matrix indicated for surgical and traumatic wounds. Restrata’s synthetic electrospun matrices are structurally similar to human tissue. This unique design resists enzymatic degradation, provides both flexibility and strength, and supports effective healing before fully resorbing.
Acute Wound Care & Compression Devices is a trusted provider of advanced pneumatic compression therapy for the treatment of venous and lymphatic diseases, backed by over 30 years of industry experience. Acute Wound Care & Compression Devices is fully licensed with Medicare and Medicaid and holds certifications from HQAA and AHCA, reflecting a strong commitment to quality, compliance, and patient care.
AngioAdvancements offers proprietary medical devices designed to manage and deliver medical gases. The AngiAssist® Medical Gas Management System and the CO2mmander® ELITE Portable Medical CO2 Delivery Systems solve the issues that previously existed in the management of Co2 gas. This unique technology fills a current need in established medical procedures improving upon an existing technology or device. Need is clearly-defined and acknowledged by medical professionals. Each product is manufactured in the United States and is brought to market in a manner that reduces the overall total cost of an episode of care.
AngioSafe® is redefining revascularization through the development of technologies that safely, efficiently, and predictably empower interventionalists to tackle complex lesions. Its proprietary Atheroplastya core technology platform does not require any capital equipment and simultaneously combines mechanisms and features to revascularize severely occluded arteries, simplifying one of the most complex procedures in cardiovascular interventions. With its flagship Santreva™-ATK endovascular revascularization catheter, AngioSafe is advancing a new era of vascular innovation to improve procedure predictability an outcomes for physicians addressing complex femoropopliteal interventions. Discover more at www.angiosafe.com and follow AngioSafe on LinkedIn.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. Artivion’s four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.
AtriCure’s cryoICE cryoSPHERE MAX™ probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
At Cook Medical, we are passionate about making unique, quality medical devices and connecting with people to improve lives. Founded on inventing, manufacturing, and delivering medical devices, we provide healthcare professionals with the tools they need to help their patients return to living. Our commitment to innovation involves bringing new products to market and keeping existing products relevant to a changing healthcare landscape. We believe in using our business to help people and communities thrive by creating inclusive, supportive, and healthy environments. We are proud of our history of innovative firsts and the impact we have on patients and communities. With headquarters in Bloomington, Indiana, and manufacturing facilities and offices in various global locations, we challenge ourselves to maintain a global perspective while focusing on local impact. Follow Cook Medical at CookMedical.com and on LinkedIn.
GE HealthCare Hybrid Operating and advanced visualization tools
Gore engineers medical devices that treat a range of cardiovascular and other health conditions. With more than 55 million medical devices implanted over the course of more than 45 years, Gore builds on its legacy of improving patient outcomes through research, education and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians, hospitals and insurers. Gore is joined in service with clinicians and through this collaboration we are improving lives.
Humacyte, Inc. (Nasdaq: HUMA) develops a biotechnology platform focused on universally implantable, bioengineered human tissues designed to improve patient care. The Company manufactures acellular tissues to address a range of diseases, injuries, and chronic conditions. Its Biologics License Application for Symvess, the acellular tissue engineered vessel (ATEV) for vascular trauma, was approved by the FDA in December 2024. ATEVs are also in late stage clinical trials for arteriovenous (AV) access and peripheral artery disease (PAD). Additional preclinical programs target cardiac, metabolic, and surgical applications. For more information, visit www.Humacyte.com. For uses other than the FDA approval in the extremity vascular trauma indication, the ATEV is an investigational product and has not been approved for sale by the FDA or any other regulatory agency.
InspireMD is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. We empower physicians and patients to choose carotid stenting without compromise, delivering smart design for stroke prevention through our proprietary MicroNet™ mesh technology. Uniquely engineered on the outside of the stent scaffold, our mesh is designed to reduce plaque prolapse and provide exceptional neurovascular protection during and after carotid procedures.
VasQ™ extravascular support is designed to improve surgical AV fistula outcomes by providing permanent reinforcement to the artery-vein connection, promoting stability against wall tension, and an optimal hemodynamic angle for reduced turbulent flow. To learn more about VasQ, visit https://www.laminatemedical.com.
LeMaitre is a provider of medical devices and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable devices used primarily by vascular surgeons.
LifeNet Health is the world’s most trusted provider of transplant solutions, from organ recovery and technologically advanced clinical biologics and cellular therapies to life sciences solutions that support drug discovery and medical innovation. As a leader in regenerative medicine, LifeNet Health always honors the donors, healthcare professionals, and scientists who make the healing process possible.
Medtronic’s Aortic and Vascular portfolio focuses on advanced, minimally invasive solutions for the diagnosis and treatment of peripheral vascular disease and aortic conditions. It includes stent grafts, balloons, guidewires, and drug-coated technologies designed to restore blood flow, repair aneurysms, and improve long-term patient outcomes while reducing procedural risk and recovery time.
OPC Prosthetic Centers is a clinical provider specializing in the evaluation, design, fabrication, and management of prosthetic care for individuals with limb loss. OPC utilizes evidence-based practices, advanced prosthetic technologies, and interdisciplinary collaboration to deliver individualized treatment plans focused on functional outcomes, mobility optimization, and long-term patient success. Through ongoing assessment, patient education, and continuity of care, OPC supports rehabilitation goals while promoting safety, efficiency, and improved quality of life.
Designed for the management of chronic and acute wounds, our portfolio of advanced wound care solutions can support patients from early in the wound healing process through to wound closure regardless of wound type.
Headquartered in Alameda, California, Penumbra designs, develops, manufactures and markets novel products that address challenging medical conditions with significant unmet need.
Reflow Medical is a global company that partners with leading physicians to develop innovative technologies addressing unmet clinical needs in the endovascular treatment of complex cardiovascular disease. The company’s portfolio includes coronary and peripheral microcatheters, crossing catheters, and a revolutionary stent system enabling Retrievable Scaffold Therapy (RST). The coronary Cora Microcatheter line is FDA cleared. The peripheral product line includes Wingman™, Spex®, Spex LP, and Spur®, which have FDA clearance and CE Mark registration. Reflow Medical is headquartered in San Clemente, California.
Vascular boot and amputation devices that promote limb healing and protection.
Shape Memory Medical is reshaping clinical success through the science of smart polymer. Smart polymer upgrades device performance and redefines embolization possibilities. Our conformable smart polymer delivers unparalleled volume, returns imaging clarity, and promotes healing as the material absorbs. We continue to drive a cross-specialty portfolio to meet procedural demands.
Surmodics develops endovascular devices designed to be simply better. Our portfolio includes the Pounce™ Thrombectomy Platform and Pounce™ Venous Thrombectomy System for grab-and-go peripheral arterial and venous clot removal, and the Sublime™ Platform, which brings high performance to transradial peripheral interventions above and below the knee. Rx only.
Synovis Micro Companies Alliance, Inc. is dedicated to bringing microsurgeons advancements in products and services. In pursuit of being “The Microsurgeon’s Trusted Resource,” we are committed to the values of trust, mutual respect, open communication, and a spirit of cooperation.
At Terumo Aortic, we partner with our customers to revolutionize aortic care. We deliver innovation, versatility and precision with the broadest range of solutions that can be personalized for every patient. We are further complementing our implantable device portfolio through the development of digital technologies.
The Florida Department of Health’s Tobacco Free Florida campaign is a statewide cessation and prevention campaign funded by Florida’s tobacco settlement fund. Since the program began in 2007, more than 350,000 Floridians have successfully quit using one of Tobacco Free Florida’s free tools and services. There are now approximately 451,000 fewer adult smokers in Florida than there were 10 years ago, and the state has saved $17.7 billion in health care costs. To learn more about Tobacco Free Florida’s Quit Your Way services, visit TobaccoFreeFlorida.com or follow the campaign on Facebook at Facebook.com/TobaccoFreeFlorida or on X at X.com/tobaccofreefla.
Built around the needs of the patient, the UF Health Heart & Vascular Hospital is designed with safety and efficiency in mind. Patients have streamlined access to highly specialized, comprehensive outpatient treatment options and inpatient services in one location. Our heart patients also benefit from compassionate care delivered by outstanding faculty physicians and clinical experts collaborating in a world-class medical facility. The UF Health Heart & Vascular Hospital is designed to meet their unique needs, with improved efficiency and operations as well as a welcoming, accessible design.